reports have suggested, mainly based on indirect evidence, that the reduction of communicable diseases as a result of vaccination in many Western countries may have resulted in an increased risk of atopic diseases [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] and contributed to the contemporary asthma epidemic. 1 To support these suggestions, an elaborate theory postulates that cellmediated immunity has been altered in the absence of childhood viral infections and tuberculosis, resulting in T helper cell (T H 2)-mediated responses that lead to IgE antibody responses, which are thought to be responsible for the manifestations of atopic diseases. 1, 8 Some direct evidence from West Africa 7 endorses this theory. In GuineaBissau, a cohort of 395 children aged 6 years or younger was studied in 1978-1980 without surveying baseline information on atopic status. The cohort was followed up until 1994, when 262 children with reliable measles history were located alive, and the prick test with common allergens was performed. The survivors of measles had a prevalence of atopy about 50% lower than those who had not experienced the infection.
We explored the hypothesis that natural measles infection prevents allergic diseases using recorded information on the history of measles and atopic disease in Finland's national measlesmumps-rubella (MMR) vaccination program. [11] [12] [13] Measles did not disappear from Finland after the singledose monovalent measles vaccination program started in 1975, and wild measles virus was still circulating in 1982 when the comprehensive MMR program was launched.
METHODS

Vaccinations and Setting
In Finland, children are vaccinated free of charge by public health nurses at child health care centers. Vaccinations are voluntary. When the triple vaccine was introduced, special arrangements were made to register all MMR vaccinations between November 1, 1982, and June 30, 1986 . At the time of vaccination, data were collected on history of measles and atopic diseases and form the basis of this study. Details of the collected data and the vaccination setting have been described previously. [11] [12] [13] 
Subjects and Data
A public health nurse vaccinated the child or adolescent and recorded data on the vaccinee by interview of the parent or adolescent; the data included social security number and age at vaccination. The nurse also asked whether the vaccinee had ever been diagnosed as having eczema, allergic rhinitis (hay fever), allergic conjunctivitis, asthma or repeated episodes of obstructive bronchitis, or measles. In a representative subsample of the vaccinees, all children who received their MMR shot in November and December 1982 (including 23 785 six-year-olds) were asked for the number of regular daily child contacts. In Finland practically all preschoolers attend day care groups of varying size; the law requires access to day care for all children and the majority of mothers work.
14 Most popular are the local municipality nurseries, which tend to have large numbers (eg, 50-100) of preschoolers, from 10-month-old infants to 6-year-olds, under the same roof. The other type is family day care, which involves 4 to 5 preschoolers in addition to the children of the day care provider. The fertility rate in Finland in 1980-1985 was between 1.65 and 1.74, 15 and the average number of children in families is close to 2.
Statistical Methods
The prevalences of allergic diseases among those who had and had not had measles were compared. Age adjustment for prevalence ratios was performed using the Mantel-Haenszel method (Epi Info Version 5.01, Centers for Disease Control and Prevention, Atlanta, Ga, 1993) over 11 age strata. The method of Greenland and Robins 16 was used to estimate 95% confidence intervals (CIs) of the prevalence ratios. Because the prevalence of allergy and measles history might have differed between urban and rural areas, larger urban areas (towns with Ͼ100 000 inhabitants) and smaller municipalities were analyzed separately. First-order interactions with respect to age and urbanization were checked by stratified analysis. The effect of daily contacts on the prevalence ratio was analyzed among 6-year-old vaccinees and adjusted over 4 precoded daily child contact strata (Ͻ5, 5-6, 7-8, and Ͼ8), again using the Mantel-Haenszel 
RESULTS
Of 547 910 subjects, 20 690 had had measles; 52 087, eczema; 17 131, rhinitis; and 10 058, asthma. There was the expected increase with age in the proportion of vaccinees with a measles history, both in the municipalities with 100 000 or fewer inhabitants and in large towns ( The lifetime prevalences of the 3 allergic diseases were 32% to 67% higher after age adjustment among those who had experienced natural measles infection compared with those who had not (TABLE 2). The prevalence ratios were stable by age: in only 2 of 33 age strata was an allergic symptom more common among those without a measles history (TABLE 3) . Restricting analyses to large towns and smaller municipalities, or adjusting for possible effects of age, did not change the findings. When no stratification by area was made, the age-adjusted prevalence ratio of atopic manifestations among those who had had measles compared with those who had not was 1.32 (95% CI, 1.27-1.36) for eczema, 1.41 (95% CI, 1.33-1.49) for rhinitis, and 1.67 (95% CI, 1.54-1.79) for asthma. The prevalence ratios for allergic diseases were slightly lower when analyses were restricted to vaccinees for whom there was information on the number of daily child contacts, but adjustment for daily contacts among these 6-year-old vaccinees did not change the direction of the association (TABLE 4) . However, only the relationship between measles and asthma remained statistically significant, probably because of the much smaller sample size.
The vaccination coverage rate increased similarly among 1-to 7-year-old children with atopic manifestations and those without atopy in all large towns during the first 2 years after the national vaccination program was launched and measles incidence in the country decreased rapidly.
COMMENT
In this large national study, there was substantially more atopic disease among children and adolescents with a history of naturally occurring measles infection compared with those without a measles history. This is contrary to previous findings. 7, 8 However, although the study by Bodner and colleagues 8 found a weak inverse association of measles and atopy, they found a positive association between measles, mumps, or varicella before age 3 years and atopy.
In a survey of this type, errors in the diagnosis of atopy and measles are unavoidable. Nevertheless, it is unlikely that erroneous diagnoses of allergic manifestations differed with respect to measles history, and vice versa. Thus, we do not believe that information bias could explain our results, especially because our hypothesis received public attention only in the late 1990s and could not have influenced the information obtained from the vaccinees. Selection bias due to measles-related mortality is also unlikely because Finland has had very low measles mortality for many decades, and overall only about 1% of the population died at younger than 20 years of age in the 1980s. 15 It is also unlikely that atopic children with a previous measles history would have been especially prone to vaccination; approximately 97% of the target population was traced and vaccinated. 12 In an environment in which measles exposure was changing rapidly, a slower in- crease in vaccination coverage among atopic vs nonatopic children may have resulted in a positive association between measles history and prevalence of allergic diseases. However, the vaccination coverage rates rose similarly among atopic and nonatopic children in all larger towns during the fastest decrease in measles incidence. In theory, it is possible that atopy-prone children might be more readily attacked by measles than others. 17 Major sources of confounding, such as age and area of residence, were properly controlled for and did not change the result that those who had had measles had more atopy. An additional potential confounder is family size, especially because young siblings in large families tend to have a low risk of atopic disease. 3, 4, 8 On the other hand, large family size increases the likelihood of previous measles at the time of vaccination. 18 Thus, large family size tends to exaggerate the potential protective effect of natural measles infection against atopy, ie, it would act as a negative confounder. The number of daily child contacts has a similar effect on catching measles as family size.
All studies on the subject matter are limited by being cross-sectional. [2] [3] [4] [5] [6] [7] [8] 10 In fact, the original finding by Shaheen et al 7 10 have suggested causality based on the theory that lack of exposure to microbes early in life skews cell-mediated immunity toward T H 2 responses, favoring atopic manifestations. 1 However, immunological experts have warned against making oversimplifications from the theory. 21 For example, the lack of communicable diseases in some island populations is not the only feasible reason for their high asthma prevalence rates. 2 Because atopic asthma has a strong genetic predisposition, 22 high rates could also be explained by the genetic founder effect.
In summary, a strong positive association between measles and atopy was observed in a large Finnish population. The most common allergic diseases were substantially more prevalent in children and adolescents with a measles history than without. We do not know whether this association reflects a causal effect. These findings do not lend support to the hypothesis that experiencing natural measles infection offers protection against the main atopic diseases. 
